Experts' Perspectives: Optimal Levels for Patient Knowledge on Biosimilars

A trio of healthcare providers offer perspective on educating patients regarding biosimilar and interchangeability.

Related Keywords

United States ,Jamie Thale Brogan ,Weill Cornell ,Bincy Abraham ,Ryan Haumschild ,Winship Cancer Institute ,Academic Division Of Gastroenterology ,Public Health Service Act ,Drug Administration ,Emory Healthcare ,Academic Division ,Houston Methodist ,Thale Brogan ,Drug Evaluation ,